Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: GSK-(GlaxoSmithKline)

HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O6
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O4
May 04, 2020
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus...
London, United Kingdom
Outbreak of the coronavirus disease (COVID-19) in London
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs
GSK-RESULTS/
RTX7AKVN
November 26, 2019
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline...
STEVENAGE, United Kingdom
A scientist studies cancer cells inside white blood cells through a microscope at the GSK research centre...
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVJ
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVG
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKVA
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV9
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV7
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV6
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV5
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV4
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV3
November 26, 2019
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre...
STEVENAGE, United Kingdom
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV2
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKV1
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUX
November 26, 2019
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
A scientist prepares stem cells for research at the GSK research centre in Stevenage
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUR
November 26, 2019
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,...
STEVENAGE, United Kingdom
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKUP
November 26, 2019
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November...
STEVENAGE, United Kingdom
A GSK logo is seen on a flag at a GSK research centre in Stevenage
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSX
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
GSK-RESULTS/
RTX7AKSP
November 26, 2019
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019....
STEVENAGE, United Kingdom
A GSK logo is seen at the GSK research centre in Stevenage
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls
BRITAIN-EU/
RTX6G1C7
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BS
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BP
October 22, 2018
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland,...
MONTROSE, United Kingdom
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland...
GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley tours GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BK
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BD
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
BRITAIN-EU/
RTX6G1BB
October 22, 2018
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
MONTROSE, United Kingdom
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley...
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS
SINGAPORE-PHARMACEUTICALS/
RTX5CFOE
March 25, 2018
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore
A general view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFO9
March 25, 2018
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNY
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNU
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNQ
March 25, 2018
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An aerial view of GSK Asia House is seen in Singapore
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFNM
March 25, 2018
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
A SMRT train travels past GSK Asia House in Singapore
A SMRT train travels past GlaxoSmithKline (GSK) Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFMP
March 25, 2018
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore,...
Singapore, Singapore
The GSK logo on the facade of GSK Asia House is seen through vertical louvres in Singapore
The GlaxoSmithKline (GSK) logo on top of GSK Asia House is seen through vertical louvres in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFMD
March 25, 2018
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture...
Singapore, Singapore
The GSK logo is seen on top of GSK Asia House in Singapore
The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFM9
March 25, 2018
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An exterior view of GSK Asia House is seen in Singapore
An exterior view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
SINGAPORE-PHARMACEUTICALS/
RTX5CFM6
March 25, 2018
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken...
Singapore, Singapore
An aerial view of GSK Asia House is seen in Singapore
An aerial view of GlaxoSmithKline (GSK) Asia House is seen in Singapore, March 21, 2018. Picture taken March 21, 2018. REUTERS/Loriene Perera
GSK-CEO/
RTX3ICS3
October 26, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain, October 9, 2017. Picture taken October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQOY
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing...
GlaxoSmithKline (GSK) CEO, Emma Walmsley, and Vodafone CEO Vittorio Colao, arrive for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQJZ
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street...
GlaxoSmithKline (GSK) CEO, Emma Walmsley, carries documents as she arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
BRITAIN-EU/BUSINESS
RTS1FQJW
October 09, 2017
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London,...
London, United Kingdom
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London
GlaxoSmithKline (GSK) CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London, Britain October 9, 2017. REUTERS/Toby Melville
WITTY-MILKEN/
RTX2CIL8
May 03, 2016
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills,...
Beverly Hills, UNITED STATES
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills...
Andrew Witty, CEO of GlaxoSmithKline, speaks at the Milken Institute Global Conference in Beverly Hills, California, U.S., May 2, 2016. REUTERS/Lucy Nicholson
GLAXOSMITHKLINE-RESULTS/
RTX2BGT5
April 25, 2016
Signage for GlaxoSmithKline is seen on it's offices in London, Britain, March 30, 2016. REUTERS/Toby...
London, United Kingdom
Signage for GlaxoSmithKline is seen on it's offices in London, Britain
Signage for GlaxoSmithKline is seen on it's offices in London, Britain, March 30, 2016. REUTERS/Toby Melville/File Photo GLOBAL BUSINESS WEEK AHEAD PACKAGE - SEARCH 'BUSINESS WEEK AHEAD APRIL 25' FOR ALL IMAGES
GSK-CHINA/
RTX1VVWO
November 26, 2015
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during...
Shanghai, China
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during...
Herve Gisserot, general manager for GSK China, poses for a photograph in front of a company logo during an interview with Reuters at an office in Shanghai, China, November 25, 2015. GlaxoSmithKline Plc has cut 40 percent of its sales reps in China and axed some units as it eyes a return to growth in 2016, after sales plunged during a bribery scandal that landed it with a record $490 million fine in 2014. Picture taken November 25. To match Interview GSK-CHINA/ REUTERS/Ben Hirschler
BRITAIN-ROYALS/
RTR4DWP1
November 12, 2014
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with a wheelchair athlete during her visit to a SportsAid...
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOY
November 12, 2014
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GSK Human Performance Laboratory...
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOU
November 12, 2014
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with young athlete during her visit to a SportsAid workshop...
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOP
November 12, 2014
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GSK Human Performance Laboratory...
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWON
November 12, 2014
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GSK Human Performance Laboratory...
Britain's Catherine, Duchess of Cambridge attends a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOJ
November 12, 2014
Britain's Catherine, Duchess of Cambridge (L) speaks with wheelchair athlete David Weir during her visit...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with David Weir during her visit to a SportsAid workshop...
Britain's Catherine, Duchess of Cambridge (L) speaks with wheelchair athlete David Weir during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOH
November 12, 2014
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWOF
November 12, 2014
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with young athlete during her visit to a SportsAid workshop...
Britain's Catherine, Duchess of Cambridge (L) speaks with young athlete Emma Allen during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWO7
November 12, 2014
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWNR
November 12, 2014
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge speaks with a wheelchair athlete during her visit to a SportsAid...
Britain's Catherine, Duchess of Cambridge speaks with wheelchair athlete Sheikh Sheikh during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
BRITAIN-ROYALS/
RTR4DWNN
November 12, 2014
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
London, United Kingdom
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a...
Britain's Catherine, Duchess of Cambridge performs a cognitive testing program during her visit to a SportsAid workshop at the GlaxoSmithKline (GSK) Human Performance Laboratory in west London November 12, 2014. REUTERS/David Parker/pool (BRITAIN - Tags: ROYALS SPORT HEALTH)
CHINA-GSK/TRIAL
RTR41P0J
August 08, 2014
A policeman tries to stop a journalist from photographing as Harvey Humphrey (2nd L), son of British...
Shanghai, China
A policeman tries to stop a journalist from photographing as Harvey Humphrey, son of British investigator...
A policeman tries to stop a journalist from photographing as Harvey Humphrey (2nd L), son of British investigator Peter Humphrey (not pictured), waits to pass a metal detector at the entrance of the Shanghai No.1 Intermediate People's Court after a break during his father's trial in Shanghai August 8, 2014. Chinese prosecutors on Friday charged Humphrey and his American wife Yu Yingzeng with illegally obtaining private information in a case that could be key to a bribery investigation against GlaxoSmithKline Plc. Humphrey and Yu ran risk consultancy ChinaWhys, whose clients included GSK, and their testimony is being closely watched for any comments on the British drugmaker. REUTERS/Carlos Barria (CHINA - Tags: CRIME LAW HEALTH BUSINESS)
CHINA-GSK/TRIAL
RTR41P0H
August 08, 2014
Harvey Humphrey (C), son of British investigator Peter Humphrey (not pictured), waits to pass a metal...
Shanghai, China
Harvey Humphrey, son of British investigator Peter Humphrey, waits to pass a metal detector at the entrance...
Harvey Humphrey (C), son of British investigator Peter Humphrey (not pictured), waits to pass a metal detector at the entrance of the Shanghai No.1 Intermediate People's Court after a break during his father's trial in Shanghai August 8, 2014. Chinese prosecutors on Friday charged Humphrey and his American wife Yu Yingzeng with illegally obtaining private information in a case that could be key to a bribery investigation against GlaxoSmithKline Plc. Humphrey and Yu ran risk consultancy ChinaWhys, whose clients included GSK, and their testimony is being closely watched for any comments on the British drugmaker. REUTERS/Carlos Barria (CHINA - Tags: CRIME LAW HEALTH BUSINESS)
EUROPE-PHARMACEUTICALS/ACTIVITY/
RTR3M7LO
April 22, 2014
A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014....
London, United Kingdom
A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline in London
A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GSK and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal. REUTERS/Luke MacGregor (BRITAIN - Tags: HEALTH BUSINESS)
EUROPE-PHARMACEUTICALS/ACTIVITY/
RTR3M7KB
April 22, 2014
A car transporter drives past the office of pharmaceutical giant GlaxoSmithKline (GSK) in London April...
London, United Kingdom
A car transporter drives past the office of pharmaceutical giant GlaxoSmithKline in London
A car transporter drives past the office of pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GSK and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal. REUTERS/Luke MacGregor (BRITAIN - Tags: HEALTH BUSINESS)
EUROPE-PHARMACEUTICALS/ACTIVITY/
RTR3M7JT
April 22, 2014
A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London...
London, United Kingdom
A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKlein in London
A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. Shares in European drugmakers received a shot in the arm on Tuesday amid a flurry of activity, with Novartis striking a multi-billion dollar deal with GSK and reports U.S. giant Pfizer had approached Britain's AstraZeneca over a deal. REUTERS/Luke MacGregor (BRITAIN - Tags: HEALTH BUSINESS TRANSPORT LOGO)
GSK-INDIA/OPENOFFER
RTX16KNN
December 16, 2013
A woman walks past a GlaxoSmithKline Pharmaceuticals Ltd logo outside their headquarters in Mumbai December...
Mumbai, India
A woman walks past a GlaxoSmithKline Pharmaceuticals Ltd logo outside their headquarters in Mumbai
A woman walks past a GlaxoSmithKline Pharmaceuticals Ltd logo outside their headquarters in Mumbai December 16, 2013. GlaxoSmithKline Plc (GSK) has decided to spend roughly $1 billion to raise its stake in its Indian pharmaceutical unit, betting on rising demand in emerging markets as sales in developed economies slow due to a wave of patent expirations. REUTERS/Danish Siddiqui (INDIA - Tags: BUSINESS)
GSK-INDIA/OPENOFFER
RTX16KNL
December 16, 2013
A logo of GlaxoSmithKline Pharmaceuticals Ltd company is pictured outside its headquarters in Mumbai...
Mumbai, India
A logo of GlaxoSmithKline Pharmaceuticals Ltd company is pictured outside its headquarters in Mumbai
A logo of GlaxoSmithKline Pharmaceuticals Ltd company is pictured outside its headquarters in Mumbai December 16, 2013. GlaxoSmithKline Plc (GSK) has decided to spend roughly $1 billion to raise its stake in its Indian pharmaceutical unit, betting on rising demand in emerging markets as sales in developed economies slow due to a wave of patent expirations. REUTERS/Danish Siddiqui (INDIA - Tags: BUSINESS)
Sort by
Display
Items per page
Page
of 2